Discordance of histopathologic parameters in cutaneous melanoma: Clinical implications

Journal of the American Academy of Dermatology

Volumn 74, Issue 1, 2016, Pages 75-80

  Patrawala, Samit ^a   Maley, Alexander ^a   Greskovich, Caitlin ^a   Stuart, Lauren ^a   Parker, Douglas ^a   Swerlick, Robert ^a   Stoff, Benjamin ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

consensus; dermatopathology; discordance; melanoma; melanoma in situ; microstaging parameters; prognosis; second opinion

Indexed keywords

ANGIOLYMPHATIC INVASION; ARTICLE; BRESLOW THICKNESS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CUTANEOUS MELANOMA; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GOLD STANDARD; HEALTH CARE POLICY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD REVIEW; MITOSIS RATE; PERINEURAL INVASION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SKIN ULCER; THICKNESS; TUMOR BIOPSY; TUMOR INVASION; ADULT; AGED; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; MELANOMA; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; OBSERVER VARIATION; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; SKIN NEOPLASMS; STANDARDS; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; UNITED STATES;

ADULT; AGED; BIOPSY, NEEDLE; COHORT STUDIES; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBSERVER VARIATION; PATHOLOGY, CLINICAL; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84953637039     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.09.008     Document Type: Article

References (37)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics CA Cancer J Clin 2014 64 2014 9 29
2. National Comprehensive Cancer Network. Melanoma (version 3.2015). Available from: URL: http://www.nccn.org/professionals/physician-gls/pdf/melanoma.pdf. Accessed July 21, 2015.
3. A. Jemal, M. Saraiya, P. Patel, and et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006 J Am Acad Dermatol 65 2011 S17 S25 e1-e3
4. D.U. Ekwueme, G.P. Guy Jr., C. Li, S.H. Rim, P. Parelkar, and S.C. Chen The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006 J Am Acad Dermatol 65 2011 S133 S143
5. B.A. Shoo, R.W. Sagebiel, and M. Kashani-Sabet Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center J Am Acad Dermatol 62 2010 751 756
6. E.B. Hawryluk, A.J. Sober, A. Piris, and et al. Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic J Am Acad Dermatol 67 2012 727 735
7. A. Breslow Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 172 1970 902 908
8. P.J. Heenan, L.R. Matz, J.B. Blackwell, and et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia Histopathology 8 1984 717 729
9. C.P. Karakousis, L.J. Emrich, and U. Rao Tumor thickness and prognosis in clinical stage I malignant melanoma Cancer 64 1989 1432 1436
10. A.C. Buzaid, M.I. Ross, C.M. Balch, and et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system J Clin Oncol 15 1997 1039 1051
11. P.A. Gimotty, D.E. Elder, D.L. Fraker, and et al. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas J Clin Oncol 25 2007 1129 1134
12. A.B. Francken, H.M. Shaw, J.F. Thompson, and et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up Ann Surg Oncol 11 2004 426 433
13. R.A. Scolyer, J.F. Thompson, H.M. Shaw, and S.W. McCarthy The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma J Cutan Pathol 33 2006 395 396 author reply 7-9
14. W.H. Clark Jr., D.E. Elder, D. Guerry IV, M.N. Epstein, M.H. Greene, and M. Van Horn A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma Hum Pathol 15 1984 1147 1165
15. H.T. Lynch, B.C. Frichot III, and J.F. Lynch Familial atypical multiple mole-melanoma syndrome J Med Genet 15 1978 352 356
16. A.R. Rhodes, T.J. Harrist, C.L. Day, M.C. Mihm Jr., T.B. Fitzpatrick, and A.J. Sober Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas J Am Acad Dermatol 9 1983 563 574
17. C. Clemente, A.J. Cochran, D.E. Elder, and et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Program Hum Pathol 22 1991 313 319
18. R. Corona, A. Mele, M. Amini, and et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions J Clin Oncol 14 1996 1218 1223
19. P.E. de Wit, B. van't Hof-Grootenboer, D.J. Ruiter, and et al. Validity of the histopathological criteria used for diagnosing dysplastic nevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group Eur J Cancer 29A 1993 831 839
20. L.M. Duncan, M. Berwick, J.A. Bruijn, H.R. Byers, M.C. Mihm, and R.L. Barnhill Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study J Invest Dermatol 100 1993 318S 321S
21. P.H. Duray, R. DerSimonian, R. Barnhill, and et al. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions J Am Acad Dermatol 27 1992 741 749
22. M. Piepkorn The diagnostic reproducibility of melanocytic dysplasia Arch Dermatol 134 1998 1037 1039
23. E.R. Farmer, R. Gonin, and M.P. Hanna Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists Hum Pathol 27 1996 528 531
24. N. Hastrup, O.J. Clemmensen, E. Spaun, and K. Sondergaard Dysplastic nevus: histological criteria and their inter-observer reproducibility Histopathology 24 1994 503 509
25. N. Krieger, R.A. Hiatt, R.W. Sagebiel, W.H. Clark Jr., and M.C. Mihm Jr. Inter-observer variability among pathologists' evaluation of malignant melanoma: effects upon an analytic study J Clin Epidemiol 47 1994 897 902
26. J. Lock-Andersen, K. Hou-Jensen, J.P. Hansen, N.K. Jensen, H. Sogaard, and P.K. Andersen Observer variation in histological classification of cutaneous malignant melanoma Scand J Plast Reconstr Surg Hand Surg 29 1995 141 148
27. M.A. Weinstock, R.L. Barnhill, A.R. Rhodes, and G.L. Brodsky Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel Arch Dermatol 133 1997 953 958
28. P.S. Colloby, K.P. West, and A. Fletcher Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma J Pathol 163 1991 245 250
29. S. Gaudi, J.M. Zarandona, S.S. Raab, J.C. English III, and D.M. Jukic Discrepancies in dermatopathology diagnoses: the role of second review policies and dermatopathology fellowship training J Am Acad Dermatol 68 2013 119 128
30. C.M. Balch, J.E. Gershenwald, S.J. Soong, and et al. Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
31. H. Eriksson, M. Frohm-Nilsson, M.A. Hedblad, and et al. Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management Acta Derm Venereol 93 2013 411 416
32. R.L. Barnhill, J. Katzen, A. Spatz, J. Fine, and M. Berwick The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma J Cutan Pathol 32 2005 268 273
33. M.F. Azzola, H.M. Shaw, J.F. Thompson, and et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center Cancer 97 2003 1488 1498
34. K.J. Busam The prognostic importance of tumor mitotic rate for patients with primary cutaneous melanoma Ann Surg Oncol 11 2004 360 361
35. S.B. Kesmodel, G.C. Karakousis, J.D. Botbyl, and et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas Ann Surg Oncol 12 2005 449 458
36. J.F. Thompson, S.J. Soong, C.M. Balch, and et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database J Clin Oncol 29 2011 2199 2205
37. D.M. Agnese, S.F. Abdessalam, W.E. Burak Jr., C.M. Magro, R.V. Pozderac, and M.J. Walker Cost-effectiveness of sentinel lymph node biopsy in thin melanomas Surgery 134 2003 542 547 discussion 7-8